About the Event

Researchers, engineers, industry leaders in MedTech, defence, medical devices, biotech, pharmaceuticals, commercialisation professionals, start-ups, and investigators are invited to join a hybrid information session and learn about the launch of the Surface Manufacturing focused CRC Bid.

The University of South Australia is excited to announce the launch of a Surface Manufacturing-focused CRC Bid.

Join us for an information session and find out how you can be part of a bid to unlock the potential of collaborative research and innovation in Surface Manufacturing for the MedTech sector.

Why register?

Attendees will gain a comprehensive understanding of the bid proposal, featuring a dedicated discussion on the research initiatives envisaged for the MedTech industry.

About the SM CRC Bid

A lot of equipment fails at the surface. This is especially so in extreme environments, where materials are pushed to their failure point. Developing know-how, products and processes that can improve the service life of components is vital to improving productivity. This can be achieved through enhancing the surface – through claddings, heat treatments, and coatings.

In the MedTech industry, the importance of surface engineering is of paramount importance. Medical devices and equipment frequently come into contact with human tissues, bodily fluids, or other medical substances. Ensuring that these interactions are safe, effective, and consistent is crucial.

What is Surface Engineering?
Surface engineering aids in making devices more biocompatible, reducing the risk of adverse reactions when they are implanted or introduced into the human body. Moreover, it enhances the durability and functionality of instruments, ensuring that they can withstand the demanding conditions of medical environments. Whether it's a hip implant designed to resist wear over decades, a surgical tool that needs a non-stick surface, or stents that require special coatings to promote healing and reduce inflammation, surface engineering plays a pivotal role in optimizing medical technology for better patient outcomes and operational efficiency.

Event Co-Host: MTP Connect

UniSA is proud to co-host this event with MTPConnect. MTPConnect is Australia’s Growth Centre for the medical technologies, biotechnologies and pharmaceuticals sector, an independent, not-for-profit organisation established by the Australian Government to champion the continuing growth of Australia's medical products sector. For more information, click here.

Event Moderator:

Jo Close - Director MTPConnect SA | Adelaide Intermediary Program

Jo Close is a health and medical scientist with deep experience in the health, medical technologies, and pharmaceutical sectors, driving and delivering high-impact initiatives.

Jo's extensive experience in strategy, analysis, business planning and management in the research sector has been developed across 20 years working for universities, research organisations, investors, startup companies, community organisations and charities in a range of roles and discipline areas to lead and drive new innovations with strategic intention.

Jo co-founded the Medical Device Partnering Program at Flinders University in 2009 with Professor Karen Reynolds and is a Former Non-Executive Director and Chair for Cure4 Cystic Fibrosis.

Register to attend in-person

Register virtually

---